GK1-399 (formerly TTP399)
GK1-MS-201
Phase 2 small_molecule completed
Quick answer
GK1-399 (formerly TTP399) for Type 2 Diabetes Mellitus is a Phase 2 program (small_molecule) at vTv Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- vTv Therapeutics
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed